Imagining a Better Outcome for Chronic Antibody-Mediated Rejection-Will Blocking Interleukin-6 Signaling Help?
Kidney Int Rep
.
2022 Mar 3;7(4):678-680.
doi: 10.1016/j.ekir.2022.02.026.
eCollection 2022 Apr.
Authors
Thangamani Muthukumar
1
,
R John Crew
2
Affiliations
1
Division of Nephrology and Hypertension, Department of Medicine, Weill Cornell Medical Center, New York, New York, USA.
2
Division of Nephrology, Department of Medicine, Columbia University Irving Medical Center, New York, New York, USA.
PMID:
35497807
PMCID:
PMC9039899
DOI:
10.1016/j.ekir.2022.02.026
No abstract available
Publication types
Editorial